Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX1 | P07099 | 3/20 | 0.45 |
| ▸ | LMNA | P02545 | 2/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.42 |
| ▸ | HPGD | P15428 | 2/20 | 0.42 |
| ▸ | CYP19A1 | P11511 | 2/20 | 0.41 |
| ▸ | TSHR | P16473 | 3/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.40 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 2/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
| ▸ | GAA | P10253 | 1/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.40 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.39 |
| ▸ | TRPA1 | O75762 | 2/20 | 0.38 |
| ▸ | TRPM8 | Q7Z2W7 | 2/20 | 0.38 |
| ▸ | USP2 | O75604 | 1/20 | 0.37 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL295262 | 0.91 | EPHX1 (0.46) | EPHX1LMNAALDH1A1HPGDCYP19A1 | |
| SCHEMBL4888060 | 0.91 | EPHX1 (0.44) | EPHX1LMNAALDH1A1HPGDCYP19A1 | |
| SCHEMBL4888048 | 0.91 | EPHX1 (0.44) | EPHX1LMNAALDH1A1HPGDCYP19A1 | |
| SCHEMBL1073398 | 0.90 | EPHX1 (0.43) | EPHX1LMNAALDH1A1HPGDCYP19A1 | |
| SCHEMBL1073394 | 0.90 | EPHX1 (0.43) | EPHX1LMNAALDH1A1HPGDCYP19A1 | |
| SCHEMBL2128363 | 0.89 | EPHX1 (0.51) | EPHX1LMNAALDH1A1HPGDCYP19A1 | |
| SCHEMBL1072050 | 0.89 | EPHX1 (0.42) | EPHX1LMNAALDH1A1HPGDCYP19A1 | |
| SCHEMBL294434 | 0.89 | EPHX1 (0.45) | EPHX1LMNAALDH1A1HPGDCYP19A1 | |
| SCHEMBL1072054 | 0.89 | EPHX1 (0.42) | EPHX1LMNAALDH1A1HPGDCYP19A1 | |
| SCHEMBL294435 | 0.89 | EPHX1 (0.45) | EPHX1LMNAALDH1A1HPGDCYP19A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1683783-B1 | Chiral copper complex and production processes thereof and using the same | SUMITOMO CHEMICAL CO (JP) | 2012-03-14 | — | — | EP | disclosed |
| EP-1683782-B1 | Chiral copper complex and production processes thereof and using the same | SUMITOMO CHEMICAL CO (JP) | 2012-03-14 | — | — | EP | disclosed |
| EP-1797953-B1 | PROCESS FOR PRODUCING OXYGENIC COMPOUND | SUMITOMO CHEMICAL CO (JP) | 2011-01-05 | — | — | EP | disclosed |
| US-20100204038-A1 | Catalysts based on metal complexes for the synthesis of optically active chrysanthemic acid | CARLONI SILVIA | 2010-08-12 | — | — | US | disclosed |
| US-7723539-B2 | Catalysts based on metal complexes for the synthesis of optically active chrysanthemic acid | ENDURA S.P.A. (IT) | 2010-05-25 | — | — | US | disclosed |
| EP-1120402-B1 | Chiral copper complex and production processes thereof and using the same | SUMITOMO CHEMICAL CO (JP) | 2008-06-25 | — | — | EP | disclosed |
| US-20080064898-A1 | Method for Producing Oxygen-Containing Compound | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2008-03-13 | — | — | US | disclosed |
| US-20080021237-A1 | Catalysts Based on Metal Complexes for the Synthesis of Optically Active Chrysanthemic Acid | ENDURA S.P.A. (IT) | 2008-01-24 | — | — | US | disclosed |
| US-7276622-B2 | Method for producing oxygen-containing compound | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2007-10-02 | — | — | US | disclosed |
| EP-1797953-A1 | PROCESS FOR PRODUCING OXYGENIC COMPOUND | Sumitomo Chemical Company, Limited (JP) | 2007-06-20 | — | — | EP | disclosed |
| WO-2003066559-A1 | PROCESS FOR PRODUCTION OF ALDEHYDES AND KETONES | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2003-08-14 | — | — | WO | disclosed |
| US-6489505-B2 | REACTING CHRYSANTHEMIC ACID ESTER WITH HYDROGEN PEROXIDE | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2002-12-03 | — | — | US | disclosed |
| US-6469198-B2 | OBTAINED BY CONTACTING N-SALICYLIDENEAMINOALCOHOL WITH MONO OR DIVALENT COPPER COMPOUND; FORMATION OF OPTICALLY ACTIVE CYCLOPROPANE-CARBOXYLIC ESTER FROM PROCHIRAL OLEFIN AND DIAZOACETIC ACID ESTER | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2002-10-22 | — | — | US | disclosed |
| EP-1188735-A1 | Process for producing carbonyl or hydroxy compound | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2002-03-20 | — | — | EP | disclosed |
| US-20020010361-A1 | Process for producing 3,3-dimethyl-2- formylcyclopropane-carboxylic acid ester | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2002-01-24 | — | — | US | disclosed |
| US-20020004618-A1 | Chiral copper complex and production processes thereof and using the same | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2002-01-10 | — | — | US | disclosed |
| US-20010037036-A1 | Chiral copper complex catalyst composition and asymmetric production process using the same | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2001-11-01 | — | — | US | disclosed |
| EP-1120402-A2 | Chiral copper complex and production processes thereof and using the same | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2001-08-01 | — | — | EP | disclosed |
| EP-1120393-A1 | A process for producing 3,3-dimethyl-2-formylcyclopropane-carboxylic acid ester | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2001-08-01 | — | — | EP | disclosed |
| EP-1120401-A2 | Chiral copper complex catalyst composition and asymmetric production process using the same | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2001-08-01 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080064898-A1 | Method for Producing Oxygen-Containing Compound | AOC2, AOX1, CAT | EPHX1 321/4885LMNA 3622/4885ALDH1A1 36/4885 |
| US-20020010361-A1 | Process for producing 3,3-dimethyl-2- formylcyclopropane-carboxylic acid ester | ACSL6, ACSL3, TRMT1L | EPHX1 3257/4885LMNA 4764/4885ALDH1A1 3786/4885 |
| US-20010037036-A1 | Chiral copper complex catalyst composition and asymmetric production process using the same | AP1M1, UBA3, AP1S1 | EPHX1 1268/4885LMNA 4316/4885ALDH1A1 254/4885 |
| US-20080021237-A1 | Catalysts Based on Metal Complexes for the Synthesis of Optically Active Chrysanthemic Acid | SCO2, ME1, ME3 | EPHX1 4122/4885LMNA 2779/4885ALDH1A1 1925/4885 |
| US-20020004618-A1 | Chiral copper complex and production processes thereof and using the same | SOD1, XDH, NFXL1 | EPHX1 1392/4885LMNA 4559/4885ALDH1A1 19/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.